UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway.
10.1097/CM9.0000000000001708
- Author:
Zi-Nan LU
1
;
Jia SONG
2
;
Tong-Hui SUN
1
;
Gang SUN
1
Author Information
1. Department of Mammary/Head and Neck Surgery, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China.
2. Department of Institute for Cancer Research, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China.
- Publication Type:Journal Article
- MeSH:
Biomarkers, Tumor;
Breast Neoplasms/pathology*;
Cell Proliferation/genetics*;
Computational Biology;
Female;
Gene Expression Regulation, Neoplastic;
Humans;
Proto-Oncogene Proteins c-akt/genetics*;
Signal Transduction/genetics*;
TOR Serine-Threonine Kinases/genetics*;
Ubiquitin-Conjugating Enzymes/metabolism*
- From:
Chinese Medical Journal
2021;134(20):2465-2474
- CountryChina
- Language:English
-
Abstract:
BACKGROUND:Ubiquitin-conjugating enzyme E2C (UBE2C) has been shown to be associated with the occurrence of various cancers and involved in many tumorigenic processes. This study aimed to investigate the specific molecular mechanism through which UBE2C affects breast cancer (BC) proliferation.
METHODS:BC-related datasets were screened according to filter criteria in the Gene Expression Omnibus (GEO) database and The Cancer Genome Atlas (TCGA) database. Then differentially expressed genes (DEGs) were identified using Venn diagram analysis. By using DEGs, we conducted the following analyses including Gene ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), protein-protein interaction (PPI), and survival analysis, and then validated the function of the hub gene UBE2C using quantitative reverse transcription-polymerase chain reaction (RT-qPCR), cell counting kit-8 (CCK-8) assay, transwell assay, and Western blot assay.
RESULTS:In total, 151 DEGs were identified from the GEO and TCGA databases. The results of GO analysis demonstrated that the DEGs were significantly enriched with mitotic nuclear division, lipid droplet, and organic acid-binding. KEGG analysis showed that the peroxisome proliferators-activated receptor (PPAR) signaling pathway, regulation of lipolysis in adipocytes, and proximal tubule bicarbonate reclamation were significantly enriched in the signal transduction pathway category. The top three hub genes that resulted from the PPI network were FOXM1, UBE2C, and CDKN3. The results of survival analysis showed a close relationship between UBE2C and BC. The results of CCK-8 and transwell assays suggested that the proliferation and invasion of UBE2C knockdown cells were significantly inhibited (P < 0.050). The results of Western blot assay showed that the level of phosphorylated phosphatase and tensin homology deleted on chromosome 10 (p-PTEN) was obviously increased (P < 0.050), whereas the levels of phosphorylated protein kinase B (p-AKT), phosphorylated mammalian target of rapamycin (p-mTOR), and hypoxia-inducible factor-1 alpha (HIF-1α) were dramatically decreased (P < 0.050) in the UBE2C knockdown cell.
CONCLUSION:UBE2C can promote BC proliferation by activating the AKT/mTOR signaling pathway.
